Once again, chaetocin was the only HMT inhibitor to have any synergistic effect with AZA, significantly increasing FMR1 mRNA levels in two out of three FXS NSC lines tested (Figure 3C), as well as in FXS neurons (Figure 3D). The gene discussed is FMR1; the disease is fragile X syndrome.